Biotech

All Articles

ArsenalBio elevates $325M, pivots off of previous lead property

.Toolbox Biosciences is actually proceeding up. The cell therapy company has added $325 thousand in ...

Lilly- backed effective weight loss biotech files IPO

.After increasing $170 million back in February, metabolic disease-focused BioAge Labs has actually ...

Aelis' marijuana usage drug fails stage 2b, steering Indivior to review $100M option

.Aelis Farma's hopes of safeguarding a fast, positive decision on a $100 thousand option settlement ...

ProKidney halts period 3 test not needed for tissue therapy authorization

.ProKidney has stopped one of a set of period 3 trials for its cell therapy for renal disease after ...

Vaxcyte rises on 'sensational' 31-valent PCV gain versus Pfizer

.Vaxcyte revealed what professionals referred to as "impressive" period 1/2 information for its 31-v...

Recursion's mind illness trial presents little documentation of efficiency

.Recursion has actually discovered via a very early examination of its tech-enabled approach to medi...

Acepodia, Pfizer click all together for chemistry-based cell therapy

.Phone it an instance of great chemistry: Acepodia, a biotech based on Nobel Champion scientific res...

Praxis epilepsy drug minimizes seizures in phase 2 litigation

.Praxis Preciseness Medicines has racked up another midphase gain in epilepsy this year, with its so...

Three officers resign as Dyne posts blended records for DMD applicant

.After getting away a scientific grip many years back, Dyne Rehab has disclosed brand-new phase 1/2 ...

Arrowhead fires off phase 3 data in uncommon metabolic condition ahead of market encounter Ionis

.Arrowhead Pharmaceuticals has actually presented its own hand ahead of a potential showdown along w...